Company news: Medibis; Althea; Elixinol; InhaleRx; Ecofibre; Aura Therapeutics; AusCann by Martin Lane April 4, 2024April 4, 2024 Queensland-based Medibis has raised A$736k from more than 600 investors via its second Birchal crowdfunding campaign. […]
Ecofibre announces termination of chief science officer’s employment amid legal stoush by Martin Lane March 28, 2024March 28, 2024
Ecofibre directors ‘unjustly enriched’, former executive alleges as legal action is lodged in the US by Steve Jones March 5, 2024March 5, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024February 29, 2024
Ecofibre sells hemp food and animal products business to Elixinol by Martin Lane February 12, 2024February 12, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024February 1, 2024
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Ecofibre eyes commercial pathway after positive results from endometriosis studies by Martin Lane October 24, 2023October 24, 2023
Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023October 3, 2023